Ambrosia Bio

Ambrosia Bio is an Israeli food tech company founded in 2020 that specializes in developing enzyme-based bioprocesses for the global sugar replacement industry. The company’s primary focus is producing allulose, an FDA-approved rare sugar found naturally in foods like figs, raisins, and wheat. Allulose offers 70% of the sweetness of sucrose with 90% fewer calories and minimal impact on blood glucose and insulin levels. It retains sugar's sensory and culinary properties, making it a desirable alternative for reducing sugar content in food products.

Ambrosia Bio has developed a proprietary enzyme technology to convert lower-cost feedstocks, such as sugar and starch, into allulose and other specialized ingredients. The enzymes, immobilized on a resin bed, allow for continuous processing and reuse over extended periods, maintaining high stability under varying temperatures and conditions. This approach significantly reduces production costs, potentially lowering allulose prices from current market prices of several dollars per kg to USD 1.5–2.5/kg.

The company operates on a B2B model, licensing its technology to sugar producers for co-production of allulose rather than manufacturing it directly. Ambrosia Bio maintains a demonstration plant and plans to establish a small-scale facility to showcase its technology to potential partners.

Key customers and partnerships

In June 2023, Ambrosia Bio partnered with Ginkgo Bioworks to optimize its enzyme production process using Ginkgo's strain engineering and enzyme expression technologies.